When to stop immune checkpoint inhibitor for malignant melanoma? Challenges in emulating target trials
ICM Paris Brain Institute · Université Paris Cité and Université Sorbonne Paris Nord
Raphaël Porcher
Biostatistics researcher, Université Paris Cité and Université Sorbonne Paris Nord,
1 talk